Lactobacillus rhamnosus DSM33560 and Reduced Upper Respiratory Tract Infection Symptoms

• Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial.

  • 2022-02-28
  • RCT · n = 619
  • Beneficial Microbes 13(1)
  • • A. Damholt
    • M. Keller
    • K. Baranowski
    • B. Brown
    • A. Wichmann
    • C. Melsaether
    • D. Eskesen
    • V. Westphal
    • D. Arltoft
    • A. Habicht
    • Q. Gao
    • G. Crawford

  • PubMed: 34895109
  • DOI: 10.3920/BM2021.0065

  4 Insights on

  • Reduced Upper Respiratory Tract Infection Symptoms

  • High evidence
  • Large Human Trial
  • Children

  Cluster 2 was significantly enriched with children who consumed the product, indicating that the symptoms children experience during an URTI are alleviated by the intake of L. rhamnosus GG DSM 33156.

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes